Chronic Kidney Disease
Serology ‘significantly different’ between membranous vs. proliferative lupus nephritis
Proteinuria levels are not predictive of membranous lupus nephritis vs. proliferative lupus nephritis, according to data published in Rheumatology.
Medical nutrition therapy seen as cost-effective, cost-saving method for late-stage CKD
LONG BEACH, Calif. — Implementing medical nutrition therapy for patients with late-stage chronic kidney disease saved an estimated $47,000 per patient by delaying the need for dialysis, according to a poster presented here.
Investigational drug that reduces hepcidin offers promise for treating anemia
LONG BEACH, Calif. — Researchers reported results from a phase 1b/2a placebo-controlled study of DISC-0974, an anti-hemojuvelin antibody to treat anemia in patients with chronic kidney disease.
Similar outcomes seen with chlorthalidone, hydrochlorothiazide among veterans
LONG BEACH, Calif. — Progression toward chronic kidney disease was similar in a Veterans Affairs Health Care System study of patients on either chlorthalidone or hydrochlorothiazide, according to a study presented here.
Lisa Koester, ANP, CS, CNN-NP, MSN, receives Carol Mattix Award
The National Kidney Foundation has awarded Lisa Koester, ANP, CS, CNN-NP, MSN, the Carol Mattix Award at the NKF Spring Clinical Meetings in Long Beach, California.
David M. Charytan, MD, MSc, receives J. Michael Lazarus Award
The National Kidney Foundation has awarded the J. Michael Lazarus Distinguished Award to David M. Charytan, MD, MSc.
Mitral regurgitation linked to heightened risk of CKD in patients with heart failure
LONG BEACH, Calif. — Patients with heart failure who also experienced mitral regurgitation saw a doubling of their creatinine, according to data presented here.
Kathy Schiro Harvey, MS, RDN, CSR, receives Joel D. Kopple Award
The National Kidney Foundation has awarded the Joel D. Kopple Award to Kathy Schiro Harvey, MS, RDN, CSR.
FDA rejects expanded use of Dynavax’s four-dose hepatitis B vaccine for hemodialysis
The FDA has declined to approve Dynavax’s supplemental biologics license application for the expanded use of its four-dose hepatitis B vaccine regimen in adult patients on hemodialysis, according to a manufacturer’s press release.
‘Critical gap’ exists between recommended, prevalent nephrology practices
A “critical gap” between recommended and commonly used nephrology practices, including kidney replacement therapy-directed education, exists, according to a published study.